Navigating the Future: Plasma Therapy Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Plasma Therapy Market Size Growth Forecast: What to Expect by 2025?
The scale of the plasma therapy market has experienced a swift increase in the last few years. Its expansion from $0.49 billion in 2024 to $0.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.4%, can be accredited to a number of factors. These consist of an increase in chronic diseases, growing recognition of the advantages of plasma therapy, governmental backing for plasma therapy, reimbursement provisions for plasma therapy, a surge in demand for minimally invasive procedures, a rise in personalized medicine needs, and an escalating geriatric population.

How Will the Plasma Therapy Market Size Evolve and Grow by 2029?
The market size of plasma therapy is projected to see swift expansion in the coming years. A growth to $0.88 billion by 2029 is predicted, observing a compound annual growth rate (CAGR) of 12.5%. The growth for the projected period can be associated with the escalating adoption of immunoglobulins, widened applications, increased demand for treatment of rare diseases, and personalized therapies. The forecast period also expects key trends such as the advancement of novel plasma therapy methods, biological manufacturing, plasma therapies devoid of cells, integration of telemedicine, and exploration of new applications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

What Drivers Are Propelling the Growth of Plasma Therapy Market Forward?
An expected increase in osteoarthritis cases is set to propel the plasma therapy market in the future. Regarded as a safe and effective treatment method for osteoarthritis, platelet-rich plasma (PRP), a form of plasma therapy, represents a concentrated growth factor from the patient's own blood, serving to alleviate symptoms through reducing inflammation and stalling osteoarthritis progression by being directly injected into the joint. The Journal of Elsevier, a Dutch publication, highlighted in September 2023 that by 2050, global cases of osteoarthritis are predicted to grow by 74.9% (with a variability between 59.4% and 89.9%) for the knee, 48.6% (35.9% to 67.1% range) for the hand, 78.6% (57.7% to 105.3% range) for the hip, and 95.1% (68.1% to 135.0% range) for other types of osteoarthritis. Treatments such as autologous chondrocyte implantation and scaffold implants are frequently employed for osteoarthritis. As such, the growing incidence of osteoarthritis is projected to steer the plasma therapy market forward.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

Which Emerging Trends Are Transforming the Plasma Therapy Market in 2025?
Leading firms in the plasma therapy market are launching inventive products like ESG-410, to accommodate progressing demands and augment treatment modalities. Developed as an Electrosurgical Generator, the ESG-410 presents alternatives and efficiencies in treating non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. For example, in June 2023, Olympus Corporation, a medical technology enterprise from Japan, unveiled their latest electrosurgical generator, ESG-410, which is utilized for the treatment of bladder cancer and an enlarged prostate. The ESG-410 introduces advanced design features such as improved capacitors, promising superior plasma steadiness during ignition. It has quick ignition and optimized plasma stability, possessing advantages over the ESG-400, particularly in usage with a variety of loop sizes and oval buttons. The ESG-410 Electrosurgical Generator delivers progressive treatment alternatives for NMIBC and BPH via an array of resection loops, electrodes, and vaporization instruments.

What Are the Key Segments in the Plasma Therapy Market?
The plasma therapy market covered in this report is segmented -

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:
1) By Pure PRP: High Concentration PRP, Low Concentration PRP
2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors
3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF
4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3278&type=smp

Who Are the Key Players Shaping the Plasma Therapy Market's Competitive Landscape?
Major companies operating in the plasma therapy market include Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

What Geographic Markets Are Powering Growth in the Plasma Therapy Market?
The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3278

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.